Cataldo N A, Woodruff T K, Giudice L C
Department of Gynecology and Obstetrics, Stanford University Medical Center, California 94305.
J Clin Endocrinol Metab. 1993 Jan;76(1):207-15. doi: 10.1210/jcem.76.1.7678423.
The production of insulin-like growth factor (IGF) binding proteins (IGFBPs) by human luteinizing granulosa cells obtained at oocyte harvest for in vitro fertilization was studied in defined medium. Three species of IGFBP were noted on Western ligand blotting of conditioned medium. A 31-33 kilodalton (kDa) doublet identified as IGFBP-2 by immunoprecipitation was consistently seen and was shown by metabolic labeling to be synthesized de novo. IGFBP-2 production was inhibited by hCG (100 ng/mL) to 32 +/- 8% of levels in control cultures; a similar inhibition was seen with dibutyryl cAMP and forskolin, but not with FSH. IGFBP-2 production was also inhibited by IGF-II and [Leu27]IGF-II (ED50 for both 3 ng/mL) but not by IGF-I at up to 30 ng/mL. In addition to IGFBP-2, a 35-45 kDa IGFBP identified by immunoprecipitation as IGFBP-3 was variably present on ligand blots of control conditioned medium and was consistently found in medium from cells treated with IGF-I or IGF-II (ED50 3 ng/mL) but not with insulin at 2 mg/mL. No de novo synthesis of IGFBP-3 was noted, suggesting that IGFBP-3 may be released from the cell surface by ligand. A 24-kDa IGFBP consistent with IGFBP-4 was also variably noted in basal cultures. Since IGFBPs are believed to sequester IGF peptides and inhibit their action on the granulosa, control of IGFBP production may be an important step in regulating gonadotropin and IGF action in the human granulosa cell.
在限定培养基中,对为体外受精而在卵母细胞采集时获得的人黄素化颗粒细胞产生胰岛素样生长因子(IGF)结合蛋白(IGFBP)的情况进行了研究。在条件培养基的Western配体印迹上发现了三种IGFBP。通过免疫沉淀鉴定为IGFBP-2的31 - 33千道尔顿(kDa)双峰始终可见,代谢标记显示其为重新合成。hCG(100 ng/mL)将IGFBP-2的产生抑制至对照培养物中水平的32±8%;二丁酰环磷腺苷和福司可林也有类似抑制作用,但FSH无此作用。IGF-II和[Leu27]IGF-II(两者的半数有效剂量均为3 ng/mL)也抑制IGFBP-2的产生,但高达30 ng/mL的IGF-I无此作用。除IGFBP-2外,通过免疫沉淀鉴定为IGFBP-3的35 - 45 kDa的IGFBP在对照条件培养基的配体印迹上可变存在,并且在经IGF-I或IGF-II(半数有效剂量3 ng/mL)处理而非2 mg/mL胰岛素处理的细胞培养基中始终存在。未观察到IGFBP-3的重新合成,提示IGFBP-3可能通过配体从细胞表面释放。在基础培养中也可变地观察到与IGFBP-4一致的24 kDa的IGFBP。由于IGFBP被认为可隔离IGF肽并抑制其对颗粒细胞的作用,控制IGFBP的产生可能是调节人颗粒细胞中促性腺激素和IGF作用的重要步骤。